Insulin Nano- and Micro-particles and Its Composites Prepared by SAS-A by 蒋茂星
 
学校编码：10384                                          分类号  密级    










硕  士  学  位  论  文 
   
 
SAS-A 技术制备胰岛素微纳米颗粒及其复合微粒 
      Insulin Nano- and Micro-particles and Its 




指导教师姓名：李军  教授 
专  业 名 称：化 学 工 程 




答辩委员会主席：   
评阅人：   
 
























声明人（签名）：    




























作者签名：          日期：      年      月      日 





















体抗溶剂-雾化 SAS-A (supercritical anti-solvent atomization) 技术，该技术以 SEDS 
(solution enhanced dispersion by supercritical fluids) 和 PGSS (particle formation from 




t-mPR EoS 可以对这些体系的 VLE 取得较好的计算效果。进一步对上述体系的液相体
积膨胀率进行预测，t-mPR EoS 对二元体系预测结果比 PR-EoS 的预测结果的精度有
所提高，对三元体系的预测表明其在 7.8MPa 左右能更好地反映实验现象。另外，计
算还表明：CO2+丙酮体系的体积膨胀率要远远大于 CO2+乙醇体系；对 CO2+乙醇+水































的改变对胰岛素活性的影响不明显，活性均保持在 90%以上。FTIR 与 DTA 的测试结
果表明，胰岛素活性丧失与其二级结构的变化有关，即 β-折叠的增强和 α 螺旋的减
小。 



























Supercritical fluid (SCF) technology has been widely applied to various areas, and 
very important progress has been achieved. Among the applications, particle formation or 
encapsulation with assistance of SCF by using its high solvency power and expansion 
ability to lots of solvents is a hot research topic in recent decades. It is possible to control 
the morphology, particle size (PS), and particle size distribution (PSD) for the produced 
products due to the sensitivity of SCF to the operating temperature and pressure. 
Furthermore, it is also available for the formulation of those materials such as active 
substances, thermosensitive substances, which usually cannot be processed by conventional 
methods. In this thesis, supercritical anti-solvent atomization (SAS-A), which is a 
combination of SEDS (solution enhanced dispersion by supercritical fluids) and PGSS 
(particle formation from gas-saturated solution), was employed to study the precipitation of 
polyethylene glycol 6000 (PEG) and insulin microparticles, as well as PEG/insulin and 
tripalmitin/insulin composite microparticles. 
Prior to the particle formation study, the volume expansion of the liquid phases for the 
CO2/acetone and CO2/ethanol binary systems and the CO2/ethanol/water ternary system 
was investigated using the t-mPR equations of state (t-mPR EoS) and the PR equations of 
state (PR-EoS). The correlations for the published vapor-liquid equilibrium (VLE) data of 
the above systems show that both the EoS can provide fairly good VLE calculations for the 
binary systems, but t-mPR EoS gives slightly better results. The volume expansion 
prediction for the above systems and the comparison with the published data show that, 
compared to PR-EoS, t-mPR EoS gives better results for the binary systems but worse 
results for the ternary system, but provides more reasonable results around 7.8MPa. 
Moreover, the calculations indicate that the volume expansion of the CO2/acetone system is 
always larger than that of the CO2/ethanol system. The volume expansion of the ternary 
system shows a maximum point corresponding to about the CO2/ethanol mixture’s critical 
pressure (about 7.8MPa); increase in the content of ethanol can improve the maximun 
volume expansion and therefore help to enhance the removal of water. 
The SAS-A process was applied to the generation of PEG microparticles from 
different solvents (acetone, ethanol, and ethanol/water). The effect of the processing 
conditions, including operating pressure, PEG concentration, and solution flow rate, on the 














influence of using different solvents was evaluated. The PEG particles produced by using 
acetone and ethanol are generally spherical with sizes of 1-5µm and 2-15µm, respectively. 
A high pre-expansion pressure can produce spherical and discrete particles with relatively 
small size and narrow size distribution. Increasing the PEG concentration in acetone can 
evidently increase the PEG particle sizes and widen the PSD for the PEG/acetone system, 
while increasing the PEG concentration can slightly widen the PSD, but has little effect on 
the PEG particle sizes for the PEG/ethanol system in the studied concentration range. 
Decreasing the content of ethanol in the ethanol/water solution can generate irregular and 
agglomerated particles due to the difficulty of water removal. 
The SAS-A process was employed to produce insulin particles from its ethanol/water 
solutions at 45°C. The effect of the operating conditions on the morphology, size and 
bioactivity of the produced insulin particles was evaluated. The formed primary particles 
are spherical and discrete with sizes of 0.1-1.5 µm. The loss of the activity of the insulin 
particles depends on the ethanol content in the solution; other operating conditions show 
little effect on the insulin particles’ activity. It is possible to produce insulin microparticles 
with almost no loss of its bioactivity by the SAS-A process at low ethanol content (less than 
40% in mass). The FTIR and DTA analyses compared to that of the unprocessed insulin 
confirm that the changes in the content of α-helix and β-sheet decrease the protein activity. 
Finally, the SAS-A process was employed to produce PEG/insulin composite 
microparticles, and a modified SAS-A process was employed to produce tripalmitin/insulin 
composite microparticles. The effects of different carrier materials, different ratios of 
carrier/insulin on the particle morphology and PSD and the insulin release from the 
produced composites were examined. Good combination of insulin to PEG in spherical 
composites is indicated on the basis of the insulin release from the PEG/insulin composite. 
Initial burst completely disappears for the insulin release from the tripalmitin/insulin 
composite particles (particles like flowers) produced at 50°C by the modified SAS-A 
process, while the intial burst is still high (36% in 1 min) for the tripalmitin/insulin 
composite particles (large particles attached with spheres) obtained at 45°C. 
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Table 1-1. Proprieties of gas, liquid and supercritical fluid[4]. 
Fluid state Density, g/cm3 Viscosity, g/(cm·s) Diffusion coefficient, cm2/s 
Gas (0.6-2.0)×10-3 (1.0-3.0)×10-4 0.1-0.4 
SCF 0.2-0.9 (1.0-9.0)×10-4 (2.0-7.0)×10-4 









Table 1-2. Critical constants of some substances [5]. 
Substance  Formula Tc, MPa Pc, °C ρc, g/cm3 
Carbon dioxide CO2 7.39 31.06 0.448 
Water H2O 22.00 374.2 0.344 
Methanol CH3OH 7.99 240.5 0.272 
Ethanol C2H5OH 6.38 243.4 0.276 
Methane CH4 4.6 -83.0 0.16 
Ethane C2H6 4.89 32.4 0.203 
Propane C3H8 4.25 96.6 0.217 
Aether C4H10O 3.68 193.6 0.267 
Ethene C2H4 3.14 9.5 0.200 




























































(2) 超临界流体抗溶剂技术（Supercritical fluid Anti-Solvent, SAS）； 
(3) 气体饱和溶液微粒形成技术（Particles from Gas-Saturated Solutions or 
Suspensions, PGSS）。 
由于本文采用的是 SAS 技术，本章将对 RESS 过程和 PGSS 过程的原理、
流程及应用做一个简单介绍，而对 SAS 过程作重点阐述。 



















RESS 的应用。因为在 SCF（如 CO2）中有理想溶解度的物质是很少的。可以采
用加入合适的助溶剂来提高溶质在 SCF 中的溶解度，但同时又增加了过程的复
杂性和成本。另外，采用 RESS 过程，SCF 的消耗量比较大、成本较高[4]，而推
广到大规模生产时, 由于往往需要多个喷嘴或多孔盘，过程不容易控制，颗粒分
布范围较单个喷嘴变宽[17]。 
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